IL6 and hepatocellular carcinoma: Using a monocyte-selective IL-6-deficient mouse model of spontaneous inflammatory tumorigenesis, our findings directly demonstrated that the increased TAM-derived IL-6 had an amplifying effect on the inflammation response, and further promoted the occurrence and development of HCC.